These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25427389)

  • 1. [Epidemiology of inflammatory rheumatic diseases].
    Anić B
    Reumatizam; 2014; 61(2):13-8. PubMed ID: 25427389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus and risk of restless legs syndrome.
    Hassan N; Pineau CA; Clarke AE; Vinet E; Ng R; Bernatsky S
    J Rheumatol; 2011 May; 38(5):874-6. PubMed ID: 21324968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different criteria for different purposes.
    Edwards JC; Snaith ML
    J Rheumatol; 1988 Apr; 15(4):537-8. PubMed ID: 3260950
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early diagnosis in patients with systemic lupus erythematosus (SLE)].
    Gaubitz M; Schotte H
    Z Rheumatol; 2005 Nov; 64(8):547-52. PubMed ID: 16328759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibody testing. A study of clinical utility.
    Slater CA; Davis RB; Shmerling RH
    Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic diseases in China.
    Chang NC
    J Rheumatol Suppl; 1983 Nov; 10():41-5. PubMed ID: 6607346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.
    Wolfe F; Michaud K; Li T; Katz RS
    J Rheumatol; 2010 Feb; 37(2):305-15. PubMed ID: 20080915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
    Broten L; Aviña-Zubieta JA; Lacaille D; Joseph L; Hanly JG; Lix L; O'Donnell S; Barnabe C; Fortin PR; Hudson M; Jean S; Peschken C; Edworthy SM; Svenson L; Pineau CA; Clarke AE; Smith M; Bélisle P; Badley EM; Bergeron L; Bernatsky S
    J Rheumatol; 2014 Apr; 41(4):673-9. PubMed ID: 24584928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological studies of rheumatic diseases among Japanese children].
    Fujikawa S
    Ryumachi; 1998 Jun; 38(3):555-61. PubMed ID: 9721566
    [No Abstract]   [Full Text] [Related]  

  • 10. Criteria for diagnosis and classification of rheumatic diseases.
    JAMA; 1973 Apr; 224(5 Suppl):799-80. PubMed ID: 4540632
    [No Abstract]   [Full Text] [Related]  

  • 11. Adult outcomes of childhood-onset rheumatic diseases.
    Hersh A; von Scheven E; Yelin E
    Nat Rev Rheumatol; 2011 May; 7(5):290-5. PubMed ID: 21487383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New findings regarding the clinical outcome of rheumatic diseases].
    Gromnica-Ihle E; Ganser G; Genth E
    Internist (Berl); 2001 Feb; 42(2):237-8, 241-9. PubMed ID: 11244878
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of the rheumatic diseases.
    Neuberger JS; Neuberger GB
    Nurs Clin North Am; 1984 Dec; 19(4):713-25. PubMed ID: 6334842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic and therapeutic standards for rheumatic diseases in children].
    Prusek W
    Pol Merkur Lekarski; 2002 Feb; 12(68):152-6. PubMed ID: 11995255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case 11-2004: a boy with rash, edema, and hypertension.
    Dixit RK
    N Engl J Med; 2004 Sep; 351(11):1149-50; author reply 1149-50. PubMed ID: 15356317
    [No Abstract]   [Full Text] [Related]  

  • 16. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein: should it be determined in inflammatory rheumatic diseases?].
    Schwarz HA
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1962-5. PubMed ID: 6974396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of rheumatic diseases in the German Federal Republic-- current state and perspectives].
    Raspe HH; Zink A
    Z Rheumatol; 1992; 51(1):14-9. PubMed ID: 1574931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of rheumatic disease in children.
    Gäre BA
    Curr Opin Rheumatol; 1996 Sep; 8(5):449-54. PubMed ID: 8941448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
    Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.